Vuoristo M, Miettinen T A
Scand J Gastroenterol. 1987 Apr;22(3):289-94. doi: 10.3109/00365528709078593.
The contribution of various factors to diarrhoea in coeliac disease (CD) was evaluated by measuring jejunal villous height, faecal masses, faecal fat, and faecal bile acids in 8 healthy subjects and in 37 consecutive patients before and during a gluten-free diet (GFD) and while receiving cholestyramine. Jejunal villous height was inversely correlated with faecal fat but not with faecal mass or faecal bile acids. A strong positive correlation was found between faecal fat and faecal mass and between the respective changes caused by GFD in these variables, whereas the correlations between faecal bile acids and faecal volume or between these changes caused by GFD were weak or nonsignificant. The cholestyramine treatment enhanced faecal bile acid and fat excretions and increased faecal volume without a significant effect on faecal solids or on the frequency of bowel movements, which in turn was significantly reduced by GFD. Thus, the present results show that the impaired fat absorption owing to mucosal damage of the upper small intestine markedly contributes to faecal volume and the frequency of bowel movements in CD and may be an important factor responsible for diarrhoea in coeliac patients, whereas no evidence was obtained for bile acid diarrhoea in CD.
通过测量8名健康受试者以及37名连续入选患者在无麸质饮食(GFD)前、期间及服用消胆胺时的空肠绒毛高度、粪便量、粪便脂肪和粪便胆汁酸,评估了各种因素对乳糜泻(CD)腹泻的影响。空肠绒毛高度与粪便脂肪呈负相关,但与粪便量或粪便胆汁酸无关。粪便脂肪与粪便量之间以及GFD引起的这些变量的各自变化之间存在强正相关,而粪便胆汁酸与粪便体积之间或GFD引起的这些变化之间的相关性较弱或无统计学意义。消胆胺治疗增加了粪便胆汁酸和脂肪排泄,增加了粪便体积,但对粪便固体或排便频率无显著影响,而GFD则显著降低了排便频率。因此,目前的结果表明,由于上段小肠黏膜损伤导致的脂肪吸收受损显著影响了CD患者的粪便体积和排便频率,可能是乳糜泻患者腹泻的一个重要因素,而未获得CD患者胆汁酸腹泻的证据。